Mr. James Lee reports

HEALWELL AI ANNOUNCES VOTING RESULTS OF 2026 AGSM

Healwell AI Inc. has released the voting results from its annual general and special meeting of the shareholders of the company held on June 25, 2026. Shareholders representing approximately 66.83 per cent of the votes attributable to Healwell's outstanding shares attended the meeting in person or were represented by proxy.

All matters of business set out in the company's management information circular dated May 20, 2026, were passed at the meeting, including: fixing the number of directors at seven; re-electing the seven incumbent directors; reappointing Deloitte LLP as auditor of the company; and reapproving the company's equity incentive plan, including the 10-per-cent rolling limit on the number of Class A subordinate voting shares that may be issued under the plan and all unallocated options, rights and entitlements under the plan.

Additional detail on the voting is set out below.

Election of directors

A total of 387,110,853 votes, or approximately 99.90 per cent of the votes cast at the meeting, were cast in favour of the fixing the number of directors of the company at seven.

The details of the proxy voting for the election of the seven director nominees are set out below.

Reappointment of auditor

A total of 387,188,429 votes, or approximately 99.92 per cent of the votes cast at the meeting, were cast in favour of reappointing Deloitte as the external auditor of the company and authorizing the company's board of directors to fix its remuneration.

Reapproval of equity incentive plan

A total of 382,167,598 votes, or approximately 99.80 per cent of the votes cast at the meeting, were cast in favour of reapproving the company's equity incentive plan dated Dec. 22, 2020, including the rolling 10-per-cent limit on the number of Class A subordinate voting shares that may be issued under the plan and all unallocated rights, options and entitlements under the plan.

For more information on the resolutions and the business of the meeting, readers should refer to the circular, a copy of which is available under the company's profile on SEDAR+.

About Healwell AI Inc.

Healwell is a health care artificial intelligence company focused on preventive care. Its mission is to improve health care and save lives through early identification and detection of disease. Using its own proprietary technology, the company is developing and commercializing advanced clinical decision support systems that can help health care providers detect rare and chronic diseases, improve efficiency of their practice, and ultimately help improve patient health outcomes. Healwell is executing a strategy centred on developing and acquiring technology and clinical sciences capabilities that complement the company's road map. Healwell is publicly traded on the Toronto Stock Exchange under the symbol AIDX and on the over-the-counter exchange under the symbol HWAIF.